CoChat

Thyroid diseases and bone health

Open access
Williams, G. R., Bassett, J. H. D. · 2018 · Journal of Endocrinological Investigation

The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index; 37 of the 75 sources its claims cite were checked for support.

Abstract

Thyroid hormones are essential for skeletal development and are important regulators of bone maintenance in adults. Childhood hypothyroidism causes delayed skeletal development, retarded linear growth and impaired bone mineral accrual. Epiphyseal dysgenesis is evidenced by classic features of stippled epiphyses on X-ray. In severe cases, post-natal growth arrest results in a complex skeletal dysplasia. Thyroid hormone replacement stimulates catch-up growth and bone maturation, but recovery may be incomplete dependent on the duration and severity of hypothyroidism prior to treatment. A severe phenotype characteristic of hypothyroidism occurs in children with resistance to thyroid hormone due to mutations affecting THRA encoding thyroid hormone receptor α (TRα). Discovery of this rare condition recapitulated animal studies demonstrating that TRα mediates thyroid hormone action in the skeleton. In adults, thyrotoxicosis is well known to cause severe osteoporosis and fracture, but cases are rare because of prompt diagnosis and treatment. Recent data, however, indicate that subclinical hyperthyroidism is associated with low bone mineral density (BMD) and an increased risk of fracture. Population studies have also shown that variation in thyroid status within the reference range in post-menopausal women is associated with altered BMD and fracture risk. Thus, thyroid status at the upper end of the euthyroid reference range is associated with low BMD and increased risk of osteoporotic fragility fracture. Overall, extensive data demonstrate that euthyroid status is required for normal post-natal growth and bone mineral accrual, and is fundamental for maintenance of adult bone structure and strength.

Overview

CoChat Summary

TL;DR

This review summarizes how thyroid hormones regulate skeletal development and adult bone maintenance, with hypothyroidism and hyperthyroidism having opposing effects in children and excess thyroid hormone promoting bone loss in adults. It concludes that euthyroid status is required for normal growth and bone mineral accrual and that thyroid status at the upper end of the euthyroid reference range is associated with lower BMD and increased fragility fracture risk.

Key findings

  • In adults, hyperthyroidism causes high bone turnover with increased resorption and formation, shortened remodeling time, and net loss of approximately 10% of bone per remodeling cycle; severe osteoporosis from untreated thyrotoxicosis is now rare because of early diagnosis and treatment.
  • In an individual participant meta-analysis of 70,298 subjects from 13 prospective cohort studies (762,401 person-years), subclinical hypothyroidism was not associated with fracture, whereas TSH <0.01 mU/L was associated with 2-fold increased hip fracture risk and 3.5-fold increased spine fracture risk.
  • In a meta-analysis of 56,835 subjects (2,565 hip fractures) from 12 prospective cohort studies (659,059 person-years), lower TSH and higher fT4 within the reference range were associated with 22–25% increased risk of hip fracture; in the OPENTHYRO register cohort (222,138 normal-TSH plus 9,217 low-TSH individuals, 7.5 years), each SD decrease in TSH increased hip fracture risk (HR 1.45, p<0.001) and major osteoporotic fracture risk (HR 1.32, p<0.001).
  • In post-menopausal women on suppressive T4, meta-analyses showed BMD reduced by 7% at the lumbar spine (CI 4–10%) and 5% at the femur (CI 2–8%), with no prospective fracture data; pre-menopausal women showed no effect on BMD. RTHα is described in 15 THRA mutations in 11 codons affecting 29 individuals from 16 families.

Methods

  • Narrative review of published human and mouse literature on thyroid disease and bone, including large individual participant meta-analyses and register-based cohorts; no new primary data are presented.
  • The review synthesizes studies of childhood and adult hypothyroidism/hyperthyroidism, subclinical thyroid disease, euthyroid reference-range variation, TSH suppression therapy for thyroid cancer, and genetic disorders of thyroid function (TSHB, TSHR, THRA, THRB).
  • Main analysis is qualitative synthesis; no systematic search strategy, inclusion criteria, or formal quality assessment is stated in the text.

Limitations

  • The paper states that overall interpretation of adult studies is limited by heterogeneous study design, confounding factors, lack of power, and differing end-point analyses.
  • The paper states that there are no good clinical data demonstrating skeletal consequences of hypothyroidism in adults; no fracture data are available for pre-menopausal women on suppressive T4; no prospective fracture data are available for post-menopausal women on suppressive T4; and RTHβ skeletal descriptions are variable and largely restricted to case reports or case series.
  • Evident from the text: this is a narrative review without a described systematic search or quality appraisal, so the synthesis may be selective; the paper also notes that targeted prospective clinical trials are still needed.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s40618-017-0753-4

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Intramembranous and endochondral ossification. a Skull vault stained with alizarin red (bone) and alcian blue (cartilage) from post-natal day 1 showing anterior and posterior fontanelles and sutures. Schematic representation of intramembranous bone formation at a skull suture. b Proximal tibial growth pate section at post-natal day 21 stained with alcian blue (cartilage) and van Gieson (bone matrix, red). Schematic representation of endochondral ossification showing chondrocyte proliferation, differentiation and apoptosis within the growth plate
Fig. 1 Intramembranous and endochondral ossification. a Skull vault stained with alizarin red (bone) and alcian blue (cartilage) from post-natal day 1 showing anterior and posterior fontanelles and sutures. Schematic representation of intramembranous bone formation at a skull suture. b Proximal tibial growth pate section at post-natal day 21 stained with alcian blue (cartilage) and van Gieson (bone matrix, red). Schematic representation of endochondral ossification showing chondrocyte proliferation, differentiation and apoptosis within the growth plateCC BY · PubMed Central
Fig. 2 Bone remodelling cycle. The bone remodelling cycle is orchestrated by osteocytes that are entombed within the bone structure. Bone remodelling is initiated by changes in mechanical load, structural micro-damage or exposure to systemic or paracrine factors. Monocyte/macrophage precursors differentiate to mature osteoclasts and resorb bone. Differentiation is induced by macrophage colony-stimulating factor (M-CSF) and receptor activator of NFkB ligand (RANKL) and inhibited by osteoprotegerin (OPG). Following resorption, osteoblastic progenitors are recruited, synthesize an osteoid matrix and regulate its mineralization to form new bone and thus repair the defect
Fig. 2 Bone remodelling cycle. The bone remodelling cycle is orchestrated by osteocytes that are entombed within the bone structure. Bone remodelling is initiated by changes in mechanical load, structural micro-damage or exposure to systemic or paracrine factors. Monocyte/macrophage precursors differentiate to mature osteoclasts and resorb bone. Differentiation is induced by macrophage colony-stimulating factor (M-CSF) and receptor activator of NFkB ligand (RANKL) and inhibited by osteoprotegerin (OPG). Following resorption, osteoblastic progenitors are recruited, synthesize an osteoid matrix and regulate its mineralization to form new bone and thus repair the defectCC BY · PubMed Central
Fig. 3 Hypothalamic–pituitary–thyroid axis. The thyroid gland secretes the pro-hormone T4 and the active hormone T3 and circulating concentrations are regulated by a classical endocrine negative feedback loop that maintains an inverse physiological relationship between TSH, and T4 and T3
Fig. 3 Hypothalamic–pituitary–thyroid axis. The thyroid gland secretes the pro-hormone T4 and the active hormone T3 and circulating concentrations are regulated by a classical endocrine negative feedback loop that maintains an inverse physiological relationship between TSH, and T4 and T3CC BY · PubMed Central
Fig. 4 Thyroid hormone action in bone cells. Thyroid hormones enter T3 target cells via specific membrane transporters. The relative activities of the type 2 and type 3 deiodinases (D2 and D3) are regulated to ensure optimal intracellular T3 availability resulting in the displacement of the co-repressor and the binding of the co-activator and thus the physiological transcriptional activity of TRα1
Fig. 4 Thyroid hormone action in bone cells. Thyroid hormones enter T3 target cells via specific membrane transporters. The relative activities of the type 2 and type 3 deiodinases (D2 and D3) are regulated to ensure optimal intracellular T3 availability resulting in the displacement of the co-repressor and the binding of the co-activator and thus the physiological transcriptional activity of TRα1CC BY · PubMed Central

Verification

Claims the paper makes

15 Valid · 1 Not valid · 11 Not checked · 5 Own results and interpretations

12 more claims · 7 with their cited sources checked

Create a free account to see all 32 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 15

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Self-check results appear here once an independent check has confirmed them.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

1 of 1

Citations

Cites

1 retracted

Cited by

See all 276

Metadata

Authors
Williams, G. R., & Bassett, J. H. D.
Affiliations
Imperial College London (GB)
Corresponding author
Williams, G. R.
Venue
Journal of Endocrinological Investigation
Published
2017-08-29
Volume
41
Issue
1
Pages
99-109
ISSN
  • 0391-4097 (ISSN-L)
  • 1720-8386
OpenAlex
W2752632293
Cited by
276
References
92
Citations by year
2026: 32 · 2025: 35 · 2024: 34 · 2023: 34 · 2022: 36 · 2021: 30 · 2020: 29 · 2019: 26 · 2018: 15 · 2017: 1
FWCI
13.18
Type
journal article
Language
en
Open access
Locations
  • Journal of Endocrinological Investigation (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (submittedVersion, cc-by)
  • PubMed Central (submittedVersion, cc-by)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
Funders
  • Wellcome Trust (101123, 110141, 110140)
  • Horizon 2020 Framework Programme (666869)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Keywords
thyroid dysfunction, bone health, hypothyroidism, childhood hypothyroidism, growth arrest, thyroid hormone replacement, thyroid hormone resistance, thyroid hormone receptor alpha, thyrotoxicosis, osteoporosis, subclinical hyperthyroidism, osteopenia, fracture risk, postmenopausal women, bone mineral accrual, skeletal development
MeSH terms
Bone and Bones, Humans, Hypothyroidism, Mutation, Osteoporosis, Receptors, Thyroid Hormone, Thyroid Hormones, Thyrotoxicosis, Fractures, Bone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-27, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-27 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.